Mark Bodenrader SEC EDGAR Filings (CIK 0001830371)

SEC EDGAR filings, ownership reports, and insider transactions for Mark Bodenrader.

Business address
C/O Cerevel Therapeutics Holdings Inc., 131 Dartmouth Street Suite 502, Boston, MA, 02116
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Mark Bodenrader has filed 11 SEC EDGAR filings since 30 Oct 2020

Latest Filings

Recent SEC filings for Mark Bodenrader including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 05 Aug 2024 01 Aug 2024 001-39311
4 Open 4 document View SEC filing for 4 4 23 Jan 2024 19 Jan 2024 001-39311
4 Open 4 document View SEC filing for 4 4 21 Dec 2023 19 Dec 2023 001-39311
144 Open 144 document View SEC filing for 144 05 Jun 2023
4 Open 4 document View SEC filing for 4 4 05 Jun 2023 01 Jun 2023 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Feb 2023 06 Feb 2023 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Jun 2022 01 Jun 2022 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Feb 2022 09 Feb 2022 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Feb 2021 03 Feb 2021 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Oct 2020 28 Oct 2020 001-39311
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 30 Oct 2020 27 Oct 2020 001-39311

About this filer

Mark Bodenrader files with the SEC under CIK 0001830371. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages